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Abstract 
Opiate-addicts have been known to show increased susceptibility to bacterial 
infection. Lipopolysaccharide (LPS), which is a cell wall component in gram-negative 
bacterial, is a potent stimulator of inflammation. We investigated how treatment with 
morphine alters LPS-induced inflammatory responses in the rat. Chronic morphine 
exposure alone elevated serum endotoxin levels. Animals treated with morphine and 
LPS (250 µglkg) developed hypothermia, decreased mean arterial pressure (MAP), 
increased plasma thrombin anti-thrombin III (TAT) complex, and approximately 67% 
exhibited progressive intramicrovascular coagulation. Morphine also enhanced LPS­ 
induced leukocyte endothelial adhesion (LEA), suppressed leukocyte flux and 
corticosterone production, and elevated interleukin- I� ,  tumor necrotic factor-a, and 
interleukin-6 serum levels. This study presents both the molecular and cellular 
mechanisms underlying the potentiated LPS-induced inflammation and accelerated 
progression to septic shock seen with chronic morphine exposure. 
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Introduction 
Morphine is an opiate commonly used for analgesic purposes. Physicians 
frequently prescribe morphine and other opiate analogs for post-operative and long-term 
pain management. Morphine's addictive properties make it subject to abuse as its use 
can bring about a profound sense of euphoria. Morphine tolerance, in which a higher 
dose of drug is required for the same effect, begins with the init ial treatment and becomes 
apparent after 2 - 3 weeks with regular therapeutic doses (Katzung, 1992) With the onset 
tolerance comes a certain drug dependence whereby frequent drug administration is 
required in order to the negative consequences of withdrawal such as chills, sweats, 
nausea, and vomiting. It has been known for decades that this chronic opiate-tolerant 
state carries with it a series of negative immunologic consequences. Studies have shown 
that morphine suppresses lymphocyte trafficking (Flores et al . ,  1995),  the lymphocyte 
proliferative response to mitogens (Bryant et al . ,  1 9 9 1 ;  Fecho et al . ,  1995), natural killer 
T-cell activity (Gomez-Flores and Weber, 1999; Yokota et al . , 2000), the production of 
antibodies (Bussierre et al . ,  1993),  the total number of circulating leukocytes (Le Vier et 
al . ,  1994; Fecho and Lysle, 2002), and atrophy of the spleen and thymus (Patel et al . ,  
1996). 
Morphine-induced immunosuppression increases patient susceptibility to bacterial 
infection (Hilberger et al . ,  1997). Bacterial infections usually remain local but can 
become systemic if the pathogens gain access to the circulatory system. This condition is 
called bacteremia (Wheeler et al . ,  1999) . Lipopolysaccharide (LPS) is a component of 
gram-negative bacteria that is shed from the outer cell wall and is a potent endotoxin 
(Lukasiewicz and Lugowski, 2003) . While LPS has no direct toxicity, it leads to the 
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activation of the complement system and the coagulation cascade, and induces immune 
cells, such as macrophages and neutrophils, to release proteins termed endogenous 
mediators of sepsis (Parrillo, 1990). The term, sepsis, refers to bacteremia that produces 
a systemic immunological response. Septic patients suffer from either high or low body 
temperature, and an elevated heart rate, respiratory rate, and white blood cell count. At 
the molecular level, tumor necrosis factor-alpha (TNF-a), which is released from 
macrophages, is the primary mediator of sepsis (Wheeler et al . ,  1999). TNF-a activates 
the inflammatory response by causing vasodilation through the release of bradykinin and 
nitric oxide. TNF-a also increases vascular permeability, enhances leukocyte-endothelial 
interaction, and activates platelets (Parillo, 1993). In addition, TNF-a stimulates 
macrophages and endothelial cells to release interleukin- I (IL-1 ), an endogenous pyrogen 
which acts on the hypothalamus causing the fever usually associated with bacterial 
infections. IL-1, in turn, triggers the release of other pro-inflammatory cytokines, such as 
interleukin-6 (IL-6), and prostaglandins (Ato et al . ,  2002; Li et al, 2002; Itoh et al . ,  2003). 
Initially this cascade of events is protective, acting to contain and eliminate the infection. 
However, as the bacteria continue to proliferate and exude increasing amounts of 
endotoxin, sepsis can progress to septic shock (Wang et al . ,  2003; Asakura et al . ,  2003). 
Septic shock is a deadly response to bacterial infection. The mortality rate is 
high, and it is one of the most common causes of death in the intensive care unit 
(Wheeler et al . ,  1999). As many as 40% of patients in septic shock will die even with 
extensive treatment and antibiotic therapy. Septic shock causes a dramatic decrease in 
blood pressure and the onset of disseminated intravascular coagulation (DIC). The 
hypotension is caused by an excessive increase in vascular permeability, vasodilation, 
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and decreased peripheral resistance all primarily mediated through the actions cytokines 
such as IL-1 and TNF-a.(Wheeler et al . ,  1999). DIC ensues due to activation of the 
coagulation cascade via the Hageman factor (factor XII), leading to thrombosis, tissue 
ischemia, and eventual multi-organ failure (Parillo 1993;Yamaguchi et al . ,  2000). 
Another complication of DIC is excessive bleeding and hemorrhage through the 
depletion of platelets and anti-coagulant factors, such as anti-thrombin I I I .  Anti-thrombin 
III binds to circulating thrombin forming a complex of thrombin and anti-thrombin III 
(TAT) thus preventing thrombin from further potentiating the coagulation cascade. In the 
pathogenesis of septic shock, while the concentration of endotoxin or LPS is important, it 
is the inflammatory response to the endotoxin that is the key factor in determining the 
progression of sepsis. 
Inflammation is a critical component of innate immunity, being one of the initial 
responses to invading pathogens. Innate immunity refers to the non-specific host 
defenses which include barriers such as the skin and mucous membranes, immune cells 
such as natural killer cells and macrophages, blood proteins like those involved in the 
complement cascade and interferons, and inflammation. The innate immune response is 
capable of killing a broad range of invading microbes and serves to ready the adaptive 
immune response through the production and activation of cytokines such as IL- 1 ,  IL-6, 
IL-8, and TNF-a. Inducing functional leukocyte-endothelial interaction (LEI) is essential 
for the generation of an effective inflammatory response (Eppihimer and Granger, 1997). 
Under normal conditions, LEI is minimal with the majority of erythrocytes and 
leukocytes being restricted to the lumen of the blood vessel (House and Lipowsky, 1987;  
Nazziola and House, 1992 ;  Rosenkranz and Mayada, 1999) .  As a result of vascular 
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injury or infectious challenge with endotoxin, vasoactive peptides, chemoattractant 
factors, or pro-inflammatory cytokines the incidence of LEI increases. The process of 
LEI includes: ( l )  leukocyte marginalization where leukocytes leave the main flow (2) 
leukocyte rolling on the vascular endothelium through the expression of selectins on 
leukocytes and endothelial cells; (3) leukocyte adhesion via the expression of integrin, 
ICAM, and VCAM; and ( 4) leukocyte extravasation, which refers to the PECAM-1- 
mediated migration of leukocytes out of the vascular lumen and along a chemotactic 
gradient leading toward the infecting pathogen (Muller et al . ,  1993;  Salas et al . ,  2002; 
Smith et al . ,  2002). A functional LEI response to infection would consist of an increase 
in leukocyte-endothelial adhesion (LEA) accompanied by a decrease in leukocyte flux 
(FLUX,,representing the number of leukocytes traveling past a particular point in the 
venule per unit of time). This model has been used as an indicator of an intact and 
functional immune response. However, few studies have successfully examined the LEI 
response during the development of DIC due to the exacerbated LEA, decreased 
leukocyte flow, and systemic coagulation. 
While the inflammatory response is necessary for the containment and clearance 
of infections and the healing of injuries, regulatory mechanisms must be in place to 
ensure that the inflammatory response is not excessive. A major pathway through which 
the central nervous system regulates the immune system is the hypothalamic-pituitary­ 
adrenal (HPA) axis (Bateman et al. ,  1989).  The HP A axis controls the hormonal stress 
response, the mechanism by which the CNS exerts its modulatory actions on the immune 
response (Sternberg et a l . ,  1992) .  The pathway originates within an area of the 
hypothalamus called the paraventricular nucleus (PVN). The PVN secretes corticotropin- 
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releasing hormone (CRH) into the hypophyseal b1ood supply where it stimulates the 
anterior pituitary to release adrenocorticotropic hormone (ACTH) [Katsuura et al . ,  1988;  
McCoy et al . ,  1994; Lacosta et al . ,  1998] .  Then ACTH enters the blood stream and 
induces the adrenal glands to synthesize and release glucocorticoids, i .e . ,  cortisol in the 
human and corticosterone in the rat (Hansen et al. , 2002). Glucocorticoids such as 
corticosterone exert powerful anti-inflammatory effects. Previous studies have shown 
that chronic morphine treatment desensitizes the HPA axis, leading to desensitization of 
IL-1�-induced activation ofFOS immunoreactivity in the PVN (Chang et al. , 1996) and 
potentiation ofIL-1 �- induced LEA in the rat mesentery (House et al., 2001). Chronic 
morphine treatment has also been shown to induce sepsis in mice (Hilberger et al . ,  1997) .  
The current study demonstrates that rats chronically treated with morphine and 
given a subsequent intraperitoneal (i .p .) injection of LPS show increased LEI, suppressed 
production of corticosterone, and elevated levels ofTNF-a, IL-1� ,  and IL-6. In addition, 
LPS-challenged rats treated with chronic morphine developed a decrease in mean arterial 
blood pressure (MAP), reduced body temperature, and plasma TAT concentrations 
significantly greater than placebo-treated rats. Chronic treatment with morphine alone 
resulted in an increase in serum endotoxin levels. Taken together, these data provide 
insight into the physiologic phenomena associated with the progression of sepsis in 
morphine-tolerant individuals at both molecular and cellular levels .  
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Materials and Methods 
Treatment of animals. Harlan Sprague-Dawley (Indianapolis, IN) normal adult male rats, 
adrenalectomized (ADX, adrenalectomized at Harlan Sprague-Dawley) and SHAM (rats 
that underwent the same surgical procedure but retained their intact adrenal glands), 250- 
300 g, were housed in a temperature controlled environment with a 1 2 :  1 2  hour light-dark 
cycle, and fed ad libitum a standard rat diet and water. All animals were acclimated for 5 
to 7 days prior to any experimental procedures. ADX rats received 0.9% filtered saline 
instead of water in order to maintain normal physiological levels of sodium. Animal 
studies were conducted with the approval of the Institutional Animal Care and Use 
Committee (IACUC) at Seton Hall University. 
Chronic morphine treatment followed by LPS. Animals were randomly assigned to 
receive morphine sulfate or placebo pellets (75 mg morphine sulfate per pellet) [National 
Institute of Drug Abuse, Rockville, MD] via subcutaneous implantation. Treatment was 
administered in a 2 + 4 regimen where animals were given 2 pellets on day 1 and 4 
pellets on day 2 of either morphine or placebo. This regimen of chronic morphine 
treatment has been shown to produce a high degree of tolerance and dependence (Zadina 
et al . ,  1995) .  In some of our studies, an additional group of animals that received no 
treatment with morphine or placebo was included as a control and is referred to as narve 
animals. On Day 5 ,  each group of rats was randomly assigned to receive either LPS (250 
µg/kg i .p.) [from Salmonella typhimurium; lot 3 9 H 4 1 1 0 ;  S igma ,  St. Louis, MO] or an 
equal volume of saline. Two hours after the injection, the animals were prepared for 
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intravital microscopy or sacrificed and truncal blood collected for serum and plasma 
extraction. 
Intravital microscopy. Rats were anesthetized with of sodium pentobarbital (45 mg/kg) 
[Veterinary Laboratories, Inc. ,  Lenexa, KS] administered via intra-peritoneal injection. 
After 1 0  min, a tail pinch test was performed to see i f  the animal was adequately 
anesthetized. Ventral fur was removed using electric hair clippers, and the animals were 
placed on a warm heating pad. A tracheotomy was performed to facilitate respiration. 
The carotid artery was cannulated for determination of blood pressure. The mesentery 
was exteriorized through a mid-sagittal abdominal incision and draped over a transparent 
Plexiglas shelf. Exteriorized tissues were continuously topically suffused with a 1 % 
Ringer's gelatin drip solution (in mM, 3 . 4 3  KC!, 2 2 . 8 5  NaHC03, 4 . 1 9  HEPES, 0.28 
CaCb, Sigma, St. Louis, MO) maintained at 37° C. The intestine and the areas outside 
the region of interest were covered with gauze (Johnson & Johnson, New Brunswick, 
NJ), moistened, and kept warm with drip solution. The rat mesentery was observed with 
a Nikon U1v13 metallurgic microscope adapted for intravital microscopy. A Nikon 40X 
water immersion lens was used to view the field on a Panasonic TR-930A high-resolution 
video monitor. Vessel length and width were measured using the video image shearing 
technique (IPM Model 908) on and off line. Video image shearing refers to when a 
cross-section of the video image of the venule being examined is displaced or "sheared" 
either horizontally or vertically so as to have the opposing walls of the venule overlap. 
The image displacement is quantified in microns. Post-capillary venules ranging from 20 
� 40 µm were selected. All rnicrocirculatory events were recorded using a Panasonic 
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VWCD-52 video camera and a JVC HR-S3500U videocassette recorder. Leukocyte 
FLUX was determined off-line by videotape playback by counting the number of 
leukocytes rolling past a line drawn perpendicular to the vessel of interest during a 30-scc 
interval. Leukocytes sticking to the endothelium for more than 5 sec during the duration 
of the hemodynamic measurements were counted as adhering WBCs, and expressed as 
the number of LEA per 100 µm vessel length. Intravital microscopy was used to 
visualize the microvascular trees of the mesentery. Systemic mean arterial pressure 
(MAP) was measured using a strain-gauge transducer (Century Technology, CP-01) 
connected to the rat's carotid artery. MAP was calculated as the sum of 1 /3 systolic 
pressure and 2/3 diastolic pressure. 
An obvious retardation of blood flow accompanied with intermittent coagulation was 
used as a gross indicator of DIC. 
Induction of acute inflammation. During intravital microscopy, inflammation in the 
mesenteric vessels was achieved by administration of 10-7 M n-formyl-methionyl-leucyl­ 
phenylalanine (FMLP). FMLP is a chemotactic agent that was suffused for a 2 min 
interval to induce the immune response and establish that the normal inflammatory 
response was intact. FMLP was prepared the day of the experiment by dissolving the 
powder in DMSO in a ratio of I mg FMLP to 100 microlites of DMSO. At the 
concentration used, DMSO does not effect leukocyte endothelial interaction (LEI). 
Enzyme-linked immunosorbant assay for cytokines (ELISA). ELISA kits for rat TNF­ 
a, IL-1 P, and IL-6 were obtained from R & D Systems (Minneapolis, MN). At the end 
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of each experimental protocol treatment, truncal blood was collected into 1 Sml vials. 
The blood samples were centrifuged at 4° C (1000 x g) for 10 min. Serum was stored in 
aliquots at -80 ° C until use. ELISA assays were performed according to the kit 
manufacturer's procedures. 
Radioimmunoassay (RIA) for the measurement of serum corticosterone. RIA of 
corticosterone levels was performed using a commercial kit and protocol from ICN 
Pharmaceuticals, Inc. (Orangeburg, NY). Briefly, rat serum was diluted, [ 1 2 51)- tracer 
was added, and anti-corticosterone was then added in that order. The sample was 
thoroughly vortexed, centrifuged at 1000 x g for 15  min, and the supernatant decanted. 
The precipitate was counted in a Wallace Wizard 1470 Automatic gamma counter. 
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TAT immunoassay. The Enzygnost TAT microenzyme immunoassay kit (Dade Behring, 
Inc.) was used to determine plasma levels of human thrombin-antithrombin 1lI complex 
(TAT) in the naive, placebo, and morphine treated rats. Ravanat et al. ( 1996) found that 
TAT was present in a variety of species including the rat. Plasma samples, standards, and 
controls were added to a microtiter plate coated with rabbit anti-human thrombin 
antibodies; the plate was washed, and peroxidase conjugated rabbit anti-human A TIII 
antibody solution was added. Next, the plate was washed, and the chromogen POD (o­ 
phenylenediamine dihydrochloride) solution was added; the chromogen reaction was 
stopped with 0.5N sulfuric acid, and the absorbance was measured at 492 nm. Plasma 
TAT concentrations were obtained from the standard curve via their respective 
absorbance values. 
Endotoxin Assay. Using the Pyrochrome© kit with diazo-coupling (Associates of Cape 
Cod, Inc.), we assessed serum levels of the endotoxin, LPS, in naive, placebo, and 
chronic morphine treated rats. Serum samples were first divided into two categories, 
filtered (0.2 µm pore size) and unfiltered. Two fold serial dilutions were made for the 
standards ( 1 ,  0 .5,  0.25, 0 . 125 ,  and 0.063 EU/ml). Then, serum samples, standards, and 
controls were added to a 96-well microplate, and incubated with an equal volume of 
Pyrochrome© reagent. The incubation was stopped with nitrite in HCl, and then N- ( 1 -  
Naphthyl)-ethylenediamine (NEDA) was added, forming a magenta diazotized 
derivative. The absorbance was read at 540 run. Serum endotoxin concentrations were 
obtained from the standard curve by comparing the respective absorbance values. 
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Statistical analysis. Data are presented as the mean ± SE. Comparisons of data were 
made by one-way analysis of variance (ANOV A) followed by a Newman-Kculs post-hoc 
test, or by a paired or unpaired Student's t-test (Mann-Whitney). Significance was 
assessed at the either the 95% (p<0.05) or 99% (p<0.01) confidence level. Significance 
was defined as a probability of 0.05 or less. 
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Results 
The effect of chronic morphine exposure i11 combination with LPS on the incidence of 
DIC. To determine the extent of coagulation in chronic morphine-treated rats during a 
challenge with LPS, we used intravital microscopy to observe the mesenteric 
microvasculature of placebo and morphine-treated rats after LPS injection (Fig 1 ). 
Following a single i .p .  injection of LPS (250 µg/kg), 67% of the morphine-treated 
animals demonstrated disseminated intravascular coagulation (DIC) in their mesentery. 
By comparison, no placebo-treated animals showed DIC following an LPS injection. 
The effect of LPS administration 011 rat plasma concentrations of TAT i11 both placebo 
and chronic morphine treated rats. To further evaluate the extent of coagulation in 
chronic morphine-treated rats during systemic infection, we measured plasma TAT levels 
in placebo- and chronic morphine-treated rats following either normal saline or LPS 
injection (250 µg/kg; i.p.) [Fig. 2] .  There was no significant difference in TAT 
concentrations between placebo and chronic morphine-treated animals after an injection 
with normal saline. Treatment with LPS elevated plasma TAT levels in both placebo and 
chronic morphine treated rats; however, the increase from baseline was only significant 
in the chronic morphine-treated rats. 
The effect of chronic morphine treatment on rat serum endotoxin levels. To examine 
the possibility of a bacterial component being responsible for the enhanced responses to 
treatment with a non-pyrogenic dosage of LPS, we measured the serum endotoxin 
concentration in serum samples (with and without filtering) collected from naive, 
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placebo, and chronic morphine-treated rats. There was relatively little difference in 
endotoxin concentrations in the unfiltered sera of naive and placebo rats (Fig. 3A). The 
animals given chronic morphine treatment had significantly higher serum endotoxin 
levels (Fig. 3A). However, the morphine-induced increase was removed upon filtering of 
the sera, resulting in similar endotoxin concentrations among all 3 treatment groups (Fig. 
3B). 
Effects of LPS 011 LEA and FLUX in morphine- and placebo-treated rats. Both indicators of 
functional immune responses, LEA and FLUX, were used to investigate LPS-stimulated 
alterations in the inflammatory processes of naive, placebo, and chronic morphine-treated 
animals. Figure 6 shows representative photomicrographs taken of the mesentery of 
animals given placebo followed by either saline or LPS (Figs. 4A and 4C, respectively), 
or animals given chronic morphine followed by saline or LPS (Figs. 4B and 4D, 
respectively). Topical suffusion ofFMLP, a chemoattractant, caused a significant 
increase in LEA and a decrease in FLUX in all three groups (data not shown). These 
results demonstrated the mesenteric vasculature's integrity was maintained during the 
course of the intravital microscopic observation. Intraperitonial injection of LPS (250 
ug/kg) significantly enhanced LEA in both placebo- and morphine-treated rats (Fig. 5) .  
Chronic morphine treatment resulted in a significant potentiation of LPS-induced LEA 
compared to the animals given placebo (Fig. 5). Rats given chronic morphine or placebo 
showed similar leukocyte FLUX compared to the naive rats (Fig. 6). Injection of LPS 
caused a s ignificant attenuation of FLUX in both animals given chronic morphine and 
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those given placebo (Fig. 6). However, animals given chronic morphine alone did not 
show a significant alteration in either LEA (Fig. 5) or FLUX (Fig. 6) 
Adrenalectomy alters LPS-i11d11ced LEA/FLUX responses. To observe the effects of the 
HP A-axis on the regulation of the inflammation, we measured LPS-induced LEA and 
FLUX responses in adrenalectomized (ADX) and SHAM rats. An injection with LPS 
produced a transient increase in LEA (Fig. 7) as well as a gradual decrease in FLUX (Fig. 
8) in the SHAM rats. However, ADX rats demonstrated a significant decrease in LEA at 
2 hours (Fig. 7), and a greater reduction in FLUX at 1 and 2 hours following injection 
with LPS (Fig. 8). 
Chronic morphine- and LPS-induced alterations in rat serum corticosterone levels. 
The serum concentration of corticosterone in naive rats and in animals given either 
morphine or placebo pellets followed by an i .p .  injection of LPS (250 µg/kg) was 
measured (Fig. 9). Rats given morphine or placebo pellets produced serum 
corticosterone levels only slightly higher than those in the naive animals. Following an 
i .p. injection of LPS (250 µg/kg), rats given either morphine or placebo pellets had 
significantly higher serum concentrations of corticosterone (472.9 ± 3 1 . 2  and 573.9 ± 
14 .5 ng/mL, respectively) than the animals given normal saline (46.4 ± 25.0 and 59.0 ± 
1 1 . 8  ng/mL, respectively). However, the increase seen in morphine-treated rats was 
significantly less than that in the animals given placebo pellets. 
20 
The effect of chronic morphine treatment 011 rat serum levels of the pro-inflammatory 
cytokines, IL-IP, TNF-a, and IL-6. To determine the effects of chronic morphine on 
inflammatory processes at the molecular level, we examined the effects of morphine 
treatment and/or LPS on the serum levels of three pro-inflammatory cytokines, IL-Ip,  
TNF-a, and IL-6, in naive rats and in animals treated with morphine or placebo pellets. 
The effect of chronic morphine alone on serum cytokine levels was measured over 5 days 
(Fig. I OA, B, and C). Levels of IL-1 p, TNF-a, and IL-6 increased only slightly with a 
subsequent reduction to baseline after 3 - 5 days. The serum concentrations of all three 
cytokines was negligible in the naive rats and in the animals given morphine or placebo 
pellets followed by an injection of normal saline (Fig. 1 1  A, B and C). Chronic exposure 
to morphine did not alter the basal level of serum cytokines. Following an i.p. injection 
of LPS (250 µg/kg), both morphine- and placebo-treated animals had a significantly 
higher serum concentration in these cytokines compared to the animals given normal 
saline. In addition, rats given morphine pellets had significantly elevated serum 
concentrations ofIL-lP ,  TNF-a, and IL-6 ( 5 1 5 . 1  ± 6 8 . 1 ,  253 .5  ± 39.7, 9673.7 ± 1774 .9 
pg/ml, respectively) in response to the LPS injection compared to animals given placebo 
pellets (287.6 ± 38 .2 ,  93 .7 ± 20.8, 2438.6 ± 735 .8  pg/ml, respectively).  
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Discussion 
The inflammatory response of the innate immune system is necessary for the 
walling-off and elimination of bacterial infections. The bacterial endotoxin, LPS, 
initiates a cascade of systemic, cellular, and molecular events that ultimately manifest in 
the typical physiological signs and symptoms of infection, i .e . ,  fever. LPS, an endotoxin 
shed from gram-negative bacteria, exerts major toxic effects via its activation of the 
immune response. A compromised immune response, as seen following chronic 
morphine exposure (Hilberger et al . ,  1997), can potentially accelerate the progression to 
septic shock during acute infection. In this study, we demonstrated the effects of chronic 
morphine treatment on the development of sepsis and septic shock in response to 
treatment with LPS at a non-pyrogenic dosage. 
We first examined the effects of an i .p. injection of LPS (250µglkg) on body 
temperature and MAP. Treatment with LPS did not significantly alter the body 
temperature of placebo treated rats. However, 30 min after the LPS injection, chronic 
morphine treated rats showed a significant depression in body temperature that continued 
for 240 min. We examined the likelihood of an attenuated flow or perfusion throughout 
the circulatory system by measuring the MAP. Chronic morphine treatment resulted in a 
significant decrease in MAP following both normal saline and LPS injections, with the 
greatest reduction in MAP being detected subsequent to LPS treatment. A reduction in 
MAP, and therefore, flow, increased the occurrence of blood coagulation. Hence, under 
intra vital microscopy, we discovered an increase in the number of mesenteric post­ 
capillary venules showing extensive coagulation in chronic morphine treated rats given a 
challenge with LPS. Further investigation demonstrated that following an LPS injection, 
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chronic morphine treated rats showed a 67% increase in DIC compared to placebo treated 
rats. We then utilized TAT as a measure of coagulability in order to assess the effects of 
chronic morphine on the progression of DIC during an LPS immune challenge. There 
was not a significant difference between placebo and chronic morphine treated rats given 
normal saline. However, the LPS-induced potentiation in plasma TAT levels was only 
significant in chronic morphine treated animals. It appears that during infection with 
LPS, chronic morphine treatment results in increased plasma TAT levels, and 
consequently, DIC. Even with a non-pyrogenic dose of LPS, chronic morphine treatment 
significantly enhanced the systemic effects of infection. 
The serum endotoxin concentrations of naive, placebo, and chronic morphine 
treated rats were then measured in order to assess whether the hypothermia, hypotension, 
and increase in DIC might also be due to an underlying infection attributable to morphine 
treatment alone. Both naive and placebo animals had negligible serum endotoxin levels. 
Conversely, treatment with chronic morphine resulted in a significant increase in the 
concentration of serum endotoxin. Filtering the serum removed the rise in endotoxin 
concentration associated with morphine treatment. This confirmed that the elevated 
endotoxin concentration seen in the assay was of bacterial origin. This is in accordance 
with a previous report by Hilberger et al. (1997) showing that morphine treatment resuted 
in the colonization of enteric bacteria in other organs including the liver, spleen, and 
peritoneal cavity, as well as an enhanced sensitivity to the lethal effects of LPS. Morpine 
has been shown to act on u-opioid receptors in myenteric plexus, submucosal plexus, and 
circular muscle layer in the gut (Ruoff et al. , 1991 ), causing a slowed peristalsis and 
facilitating bacterial trans location (Yukioka et al. , 1987 ;  Runkel et al. , 1993 ). Therefore, 
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a subsequent bacterial infection will result in a more severe response due to the chronic 
morphine-induced bacteremia. 
As previously mentioned, LEI is a functional indicator of an effective 
inflammatory response. We measured LEA and FLUX in naive, placebo, and chronic 
morphine treated rats to ascertain the effects of chronic morphine and LPS at the cellular 
level. Local suffusion of the bacterial peptide, FMLP, led to an enhancement of LEA and 
a reduction in FLUX in all treatment groups (data not shown). This demonstrates that all 
groups of animals possessed a functional immune system. Injection of a 250µg/kg dose 
of LPS produced a significant increase in LEA and reduction in FLUX in both placebo 
and morphine treated animals. Though morphine treatment alone did not significantly 
increase LEA or reduce FLUX, chronic morphine with a subsequent injection of LPS 
produced the most dramatic potentiation of LEA compared to the placebo and LPS 
treated rats. These results are consistent with our previous reports showing that chronic 
morphine treatment desensitizes the HPA axis-mediated inhibition of the inflammatory 
response (House et al., 2001) .  Without an additional exogenous challenge, the 
impairment of the HP A axis by chronic exposure to morphine apparently does not elicit a 
different basal LEI, which may be due to physiological "adaptation" in an opiate tolerant 
state. Systemic adaptation of many physiological events following chronic treatment 
with morphine has been well documented (Zadina et al., 1995). Bryant et al. ( 1 99 1 )  
showed that the elevation of circulating corticosterone following morphine pelleting is 
sustained for 72 h, and then declines to the serum level observed in placebo-pelleted 
mice. 
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Disruption of the HPA axis can have a substantial effect on LEI. To investigate 
chronic morphine-mediated desensitization of the HPA axis, we measured LEA and 
FLUX in ADX and SHAM rats given an i .p. dose of LPS. SHAM rats, whose HPA axis 
was intact, demonstrated an increase in LEA and decrease in FLUX that continued for up 
to 4 h after LPS injection. Furthermore, ADX rats showed an even greater reduction in 
FLUX at I and 2 h after LPS injection, and demonstrated a significant attenuation in LEA 
at 2 h post-injection. It seems that removal of the adrenal glands produced an 
inappropriate LEA response due to the lack of an intact HP A axis. These data are 
consistent with the observations that the corticosteroid, hydrocortisone, significantly 
attenuates the elevated LEA in ADX animals (Suzuki et al . ,  1995), and supports our 
argument that disruption of the HPA axis can potentiate the LEI response to an immune 
challenge. 
Since adrenalectomy and morphine treatment both alter LEI, we examined the 
effect of chronic morphine on serum levels of the end product of HPA axis activation, 
corticosterone. Naive, placebo, and chronic morphine treated animals given normal 
saline showed no variation in serum corticosterone levels. An injection with LPS 
resulted in a significant potentiation in the concentration of corticosterone in both the 
placebo and morphine treated groups. In response to LPS, the elevation of serum 
corticosterone levels was significantly less in the animals given morphine than in the rats 
given placebo. 
LPS stimulates immune cells, i .e . ,  macrophages, to release a variety of cytokines. 
In response to endotoxin, macrophages release cytokines, such as, TNF-a, IL-B, and IL- 
6, which play a key role in the recruitment of the body's defenses against infection (Ato 
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et al. , 2002; Li et al . ,  2002; Itoh et al . ,  2003). However, these cytokines are also central 
to the development of septic shock (Katsuyama et a l . ,  1999; Wang et al . ,  2003). We 
examined the effect of chronic morphine treatment alone and in combination with LPS on 
serum cytokine levels. Chronic morphine treatment over a 5-day period produced a 
transient yet negligible increase in all 3 cytokines. Naive, placebo, and chronic morphine 
treated rats given normal saline did not show a significant difference in cytokine 
concentrations. LPS treatment produced a significant increase in serum cytokine 
concentrations in both placebo and chronic morphine treated animals. The greatest 
potentiation in the levels of TNF-a, IL-1 �, and IL-6 were observed with chronic 
morphine treated rats injected with LPS. The increase in cytokines following LPS 
injection in morphine treated animals may be a result of the reduced corticosterone. 
Glucocorticoids have been shown to inhibit the secretion and actions of various 
cytokines. Suppression of LPS-induced corticosterone production in morphine-treated 
animals could prevent the inhibition of cytokine production, which would normally 
operate in control placebo animals. We have previously shown that injection of IL-1 � 
ablates the negative feedback of glucocorticoids on immune responses via the 
desensitization of the HPA axis, but also potentiates the positive effects exerted on 
immune responses such as LEA (Chang et al . ,  1998; House et al., 2001 ). 
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Summary 
In summary, chronic exposure to morphine desensitized the HPA response to an 
exogenous challenge, and consequently suppressed the production of glucocorticoids, 
leading to an enhanced secretion of pro-inflammatory cytokines in response to an 
immune challenge. These cytokines exert positive effects on immune responses, 
including LEI. Morphine-treated animals, in response to an LPS challenge, demonstrated 
an enhanced LEI response prior to the development of DIC. In the absence of an external 
infection, chronic morphine administration alone resulted in bacteremia that was still 
manageable by the functional yet compromised immune response. This initial increase in 
serum endotoxin created a "pre-septic" state during which a subsequently immune 
challenge led to a dramatically enhanced inflammatory response. These animals also 
developed hypothermia and hypotension, which, collectively, can lead to septic shock. 
With morphine treatment, the LPS stimulated an increase in LEI, elevation in the 
cytokines, TNF-a, IL-1 p, and IL-6, and a reduction in serum corticosterone; all of these 
responses act synergistically to further enhance the development of sepsis and septic 
shock. These studies substantiate our hypothesis that the immune response is potentiated 
when the HP A axis is compromised, and provide valuable insight into some of the 
molecular and cellular mechanisms under! ying how attenuation of the HP A axis in the 
opiate addict may accelerate the progression of septic shock. 
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